secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001193125-23-235340
Event type: other
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal adopts 2023 Inducement Plan reserving 500,000 shares for new hires ahead of commercial launch
--------------------------------------------------------------------------------

- Board adopted Inducement Plan on Sept 8, 2023, reserving 500,000 shares of common stock for equity grants.
- Plan approved without stockholder approval per Nasdaq Listing Rule 5635(c)(4); only new employees eligible.
- Plan supports expected substantial headcount increase as company prepares for commercial launch.
- Administered by Compensation Committee; awards include options, RSUs, performance awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523235340/0001193125-23-235340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523235340/d521240d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-235340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer